INS and myeloid sarcoma: Non-clinical and clinical data clearly highlight the potential of ligands for these channels, especially natural compounds such as capsaicin/capsinoids and cinnamaldehyde, to treating the various aspects of MS, from insulin resistance to atherosclerosis.